Longevity Health Holdings Inc. (XAGE)
XAGE Stock Price Chart
Explore Longevity Health Holdings Inc. interactive price chart. Choose custom timeframes to analyze XAGE price movements and trends.
XAGE Company Profile
Discover essential business fundamentals and corporate details for Longevity Health Holdings Inc. (XAGE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Sept 2021
Employees
15.00
Website
https://www.carmellcosmetics.comCEO
Rajiv Sarman Shukla
Description
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
XAGE Financial Timeline
Browse a chronological timeline of Longevity Health Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 14 Aug 2025
EPS came in at -$1.56 , while revenue for the quarter reached $503.61K .
Earnings released on 21 May 2025
EPS came in at -$4.80 , while revenue for the quarter reached $510.35K .
Earnings released on 15 May 2025
EPS came in at -$1.52 , while revenue for the quarter reached $17.48K .
Stock split effective on 14 May 2025
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$0.14 , while revenue for the quarter reached $20.52K .
Earnings released on 14 Aug 2024
EPS came in at -$0.16 , while revenue for the quarter reached $12.32K .
Earnings released on 15 May 2024
EPS came in at -$0.16 .
Earnings released on 26 Mar 2024
EPS came in at $0.29 , while revenue for the quarter reached -$3.73M .
Earnings released on 14 Nov 2023
EPS came in at -$0.62 .
Earnings released on 30 Sept 2023
EPS came in at -$0.62 , while revenue for the quarter reached $3.73M .
Earnings released on 30 Mar 2023
EPS came in at $0.03 .
Earnings released on 31 Dec 2022
EPS came in at -$0.16 .
Earnings released on 30 Sept 2022
EPS came in at -$0.32 .
Earnings released on 30 Jun 2022
EPS came in at -$0.02 .
Earnings released on 20 May 2022
EPS came in at -$0.03 .
Earnings released on 15 Apr 2022
EPS came in at -$0.01 .
Earnings released on 22 Nov 2021
EPS came in at -$0.00 .
Earnings released on 13 Sept 2021
EPS came in at -$0.00 .
XAGE Stock Performance
Access detailed XAGE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.